| Literature DB >> 31068206 |
M S Toti1, P Ghirri2, A Bartoli3, C Caputo3, E Laudani3, F Masoni3, L Mele3, R Bernardini3.
Abstract
BACKGROUND: Neonatal adrenal hemorrhage is a relatively uncommon condition (0.2-0.55%). Various risk factors have been reported in addition to birth asphyxia, such as sepsis, coagulation disorders, traumatic delivery, and perinatal injuries. Adrenal hemorrhage usually affects the right adrenal gland (about 70% of cases) while it involves the bilateral adrenal gland only in 10% of cases. In most cases, the event is asymptomatic but, in others, it may be so devastating to determine death by bleeding or adrenal insufficiency. CASEEntities:
Keywords: Adrenal insufficiency; Differential diagnosis; Hormonal therapy; Neonatal adrenal hemorrhage; Ultrasound monitoring
Mesh:
Year: 2019 PMID: 31068206 PMCID: PMC6507044 DOI: 10.1186/s13052-019-0651-9
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Fig. 1Differential diagnosis of suprarenal abdominal masses in newborn
Blood analysis of the newborn
| I day of life | III days of life | I week of life | III week of life | |
|---|---|---|---|---|
| CRP (mg/dl) | 2.3 | 6.58 | 0.42 | 0.01 |
| BT (mg/dl) | 11.2 (dir 1,6) | 12.5 (dir 0,9) | 5.9 (dir 0,6) | 1.8 |
| Hb (g/dl) | 13.9 | 10.9 | 8.4 | |
| RBC 106/μ/L | 3.87 | 4.03 | 2.55 | |
| Na mEq/L | 140 | 143 | 128 | 138 |
| K mEq/L | 4.2 | 4.4 | 5.5 | 4.7 |
| PT | 110% | |||
| aPTT | 23 s | |||
| AST U/L | 39 | |||
| ALT U/L | 16 | |||
| Ferritin ng/ml | 32 |
Fig. 2Abdominal ultrasonography revealed suprarenal bilateral lesion, well circumscribed with an inhomogeneous aspect but without vascular flow on Color-Doppler images. The images (25 mm × 16 mm right, 30 × 16 mm left) were mostly isoechoic- hyperechoic. There was a solid portion with essentially normal kidneys and no foci of blood flow within the area
Fig. 3Evolution of the echographic aspect at 15 days of life for modification of the haemorrhagic lesion. The images were mostly isoechoic-anechoic. There was a solid portion, but also fluid level, some internal echoes and minimum turbidity with normal kidneys
Steroid hormonal profile, urinary catecholamines, and other analysis of the newborn
| v.n. | 1 day of life | 10 days of life | 14 days of life | 30 days of life | 45 days of life | 60 days of life | 88 days of life | 110 days of life | |
|---|---|---|---|---|---|---|---|---|---|
| 17-OH-P ng/ml | 0.6–3.3 | 1.9 | |||||||
| DHEA-solf. μg/ml | 0.2–6.9 | 0.2 | |||||||
| Delta 4 andros. ng/ml | 0.3–3.1 | 0.3 | |||||||
| AVM (mg/24 h) | 1–11 | 0.4 | |||||||
| AOV (mg/g creat.) | 0.5–35 | 17.1 | |||||||
| Noradrenaline ug/24 h | 6 | ||||||||
| ACTH pg/ml | 4.7–49 | 107.8 | 149.6 | 46.4 | 57.3 | 24.8 | 46.8 | ||
| Cortisol μ/dl | 6.7–22.6 | 6.8 | 5.3 | 6.6 | 3.7 | 10.4 | 6.7 | 9.1 | |
| Aldosterone/renin ratio | < 5.2 | 0.8 | |||||||
| Blood culture | N | ||||||||
| Urine culture | N |
17-OH-P 17-hydroxyprogesterone, DHEA-solf. Dehydroepiandrosterone sulphate, Delta 4 andros. Delta 4 Androstenedione, AVM Vanillylmandelic acid, AOV Homovanillic acid, ACTH Adrenocorticotropic hormone
Fig. 4Ultrasound changes of NAH in follow-up with modification of the ultrasonographic appearance
Fig. 5Progressive ultrasound reduction of lesions at 45 days of life (a) and at 60 days of life (b)
Fig. 6Complete regression of adrenal hemorrhage after 88 days of life with normal renal and adrenal ultrasound appearance